aTYR PHARMA INC - COMMON STOCK (ATYR)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
97,996,626
Total 13F shares
1,727,317
Share change
+1,196,940
Total reported value
$6,046,000
Price per share
$3.50
Number of holders
15
Value change
+$4,183,916
Number of buys
10
Number of sells
5

Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q3 2019

As of 30 Sep 2019, aTYR PHARMA INC - COMMON STOCK (ATYR) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,727,317 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, FMR LLC, VIKING GLOBAL INVESTORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Glen Harbor Capital Management LLC, Meadow Creek Investment Management LLC, and BlackRock Inc.. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.